The Predictive Value of Proteome Profiling for Brain Metastasis in Limited-Stage Small-Cell Lung Cancer
Active, not recruitingOBSERVATIONAL
Enrollment
228
Participants
Timeline
Start Date
October 1, 2023
Primary Completion Date
January 30, 2025
Study Completion Date
January 30, 2025
Conditions
Small-cell Lung Cancer
Trial Locations (1)
250000
Shandong Cancer Hospital and Institute, Jinan
All Listed Sponsors
lead
Jinming Yu
OTHER
NCT06483919 - The Predictive Value of Proteome Profiling for Brain Metastasis in Limited-Stage Small-Cell Lung Cancer | Biotech Hunter | Biotech Hunter